Repurposing medications.
作者信息
Novack Gary D
机构信息
PharmaLogic Development Inc, San Rafael, CA, USA; Department of Ophthalmology & Visual Sciences, University of California, Davis, USA.
出版信息
Ocul Surf. 2021 Jan;19:336-340. doi: 10.1016/j.jtos.2020.11.012. Epub 2020 Nov 26.
Abstract
摘要
相似文献
1
Repurposing medications.
Ocul Surf. 2021 Jan;19:336-340. doi: 10.1016/j.jtos.2020.11.012. Epub 2020 Nov 26.
2
Repurposing strategies for tropical disease drug discovery.
Bioorg Med Chem Lett. 2016 Jun 1;26(11):2569-76. doi: 10.1016/j.bmcl.2016.03.103. Epub 2016 Mar 30.
3
Repurposing Drugs: An Empowering Approach to Drug Discovery and Development.
Drug Res (Stuttg). 2023 Nov;73(9):481-490. doi: 10.1055/a-2095-0826. Epub 2023 Jul 21.
4
IUPHAR review - Data-driven computational drug repurposing approaches for opioid use disorder.
Pharmacol Res. 2024 Jan;199:106960. doi: 10.1016/j.phrs.2023.106960. Epub 2023 Oct 11.
5
Repurposing Marketed Drugs as Antidepressants with In Silico, In Vivo, and In Vitro Screening Methods.
Adv Exp Med Biol. 2023;1423:271-278. doi: 10.1007/978-3-031-31978-5_27.
6
Adera2.0: A Drug Repurposing Workflow for Neuroimmunological Investigations Using Neural Networks.
Molecules. 2022 Sep 30;27(19):6453. doi: 10.3390/molecules27196453.
7
Recent Drug-Repurposing-Driven Advances in the Discovery of Novel Antibiotics.
Curr Med Chem. 2019;26(28):5363-5388. doi: 10.2174/0929867325666180706101404.
8
Drug repurposing: a promising tool to accelerate the drug discovery process.
Drug Discov Today. 2019 Oct;24(10):2076-2085. doi: 10.1016/j.drudis.2019.06.014. Epub 2019 Jun 22.
9
Revisiting Repurposing.
Assay Drug Dev Technol. 2016 Dec;14(10):554-556. doi: 10.1089/adt.2016.766.
10
Current approaches in identification of a novel drug targets for drug repurposing.
Prog Mol Biol Transl Sci. 2024;205:213-220. doi: 10.1016/bs.pmbts.2024.03.020. Epub 2024 Apr 4.
引用本文的文献
1
Repurposing the hypoglycaemic agents for neuroinflammation, a comprehensive review.
3 Biotech. 2025 Sep;15(9):281. doi: 10.1007/s13205-025-04455-7. Epub 2025 Aug 5.
2
DrugReX: an explainable drug repurposing system powered by large language models and literature-based knowledge graph.
Res Sq. 2025 Jun 16:rs.3.rs-6728958. doi: 10.21203/rs.3.rs-6728958/v1.
3
Upcycling the anthracyclines: New mechanisms of action, toxicology, and pharmacology.
Toxicol Appl Pharmacol. 2023 Jan 15;459:116362. doi: 10.1016/j.taap.2022.116362. Epub 2022 Dec 30.
4
A Randomised Phase I Study to Assess the Safety, Tolerability and Pharmacokinetics of Palovarotene Ophthalmic Solution.
Drugs R D. 2023 Mar;23(1):43-53. doi: 10.1007/s40268-022-00410-6. Epub 2022 Dec 21.
5
Applications of natural language processing in ophthalmology: present and future.
Front Med (Lausanne). 2022 Aug 8;9:906554. doi: 10.3389/fmed.2022.906554. eCollection 2022.
6
Drug repurposing: a systematic review on root causes, barriers and facilitators.
BMC Health Serv Res. 2022 Jul 29;22(1):970. doi: 10.1186/s12913-022-08272-z.
7
Recommendations for Off-Label Drug Use in Ophthalmology in China: A Clinical Practice Guideline.
Front Pharmacol. 2022 May 24;13:919688. doi: 10.3389/fphar.2022.919688. eCollection 2022.
8
Expedited regulatory product approval in the time of COVID-19.
Ocul Surf. 2022 Oct;26:345-348. doi: 10.1016/j.jtos.2022.05.007. Epub 2022 May 28.
9
The Complex Structure of the Pharmacological Drug-Disease Network.
Entropy (Basel). 2021 Aug 31;23(9):1139. doi: 10.3390/e23091139.
10
Compounded medications for ocular surface disease.
Ocul Surf. 2021 Oct;22:267-270. doi: 10.1016/j.jtos.2021.09.004. Epub 2021 Sep 20.
本文引用的文献
1
Publication rate in preclinical research: a plea for preregistration.
BMJ Open Sci. 2020 Aug 27;4(1):e100051. doi: 10.1136/bmjos-2019-100051. eCollection 2020.
2
Nature journals ink open-access deal.
Science. 2020 Oct 23;370(6515):391. doi: 10.1126/science.370.6515.391-a.
3
Hydroxychloroquine with or without Azithromycin in Mild-to-Moderate Covid-19.
N Engl J Med. 2020 Nov 19;383(21):2041-2052. doi: 10.1056/NEJMoa2019014. Epub 2020 Jul 23.
4
Remdesivir for the Treatment of Covid-19 - Preliminary Report. Reply.
N Engl J Med. 2020 Sep 3;383(10):994. doi: 10.1056/NEJMc2022236. Epub 2020 Jul 10.
5
Research progress on repositioning drugs and specific therapeutic drugs for SARS-CoV-2.
Future Med Chem. 2020 Sep;12(17):1565-1578. doi: 10.4155/fmc-2020-0158. Epub 2020 Jul 8.
6
Clinical Pharmacology Considerations for Developing Small-Molecule Treatments for COVID-19.
J Clin Pharmacol. 2020 Sep;60(9):1147-1154. doi: 10.1002/jcph.1697. Epub 2020 Jul 12.
7
Investigate Oral Zinc as a Prophylactic Treatment for Those at Risk for COVID-19.
Am J Ophthalmol. 2020 Aug;216:A5-A6. doi: 10.1016/j.ajo.2020.04.028. Epub 2020 May 26.
8
Can Colchicine as an Old Anti-Inflammatory Agent Be Effective in COVID-19?
J Clin Pharmacol. 2020 Jul;60(7):828-829. doi: 10.1002/jcph.1645. Epub 2020 May 23.
9
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial.
Lancet. 2020 May 16;395(10236):1569-1578. doi: 10.1016/S0140-6736(20)31022-9. Epub 2020 Apr 29.
10
15 drugs being tested to treat COVID-19 and how they would work.
Nat Med. 2020 May 15. doi: 10.1038/d41591-020-00019-9.
Zotero 插件